High levels of anti-Muellerian substance could increase breast cancer risk
October 10th, 2009 - 3:11 pm ICT by ANIWashington, Oct 10 (ANI): Women who have high levels of Mullerian inhibiting substance (MIS), which are known for regulating in utero sexual differentiation in boys, could be more prone to breast cancer, according to a new study.
In order to find out if MIS levels were linked with breast cancer risk, Dr. Joanne F. Dorgan, of the Fox Chase Cancer Center in Philadelphia, and colleagues conducted a prospective case-control study of 309 participants who were registered in the Columbia, Missouri Serum Bank.
The researchers collected blood samples from women with in situ or invasive breast cancer who, at the time of donation, were free of cancer.
Each of 105 breast cancer patients was matched to two control subjects.
MIS was measured in serum using an enzyme-linked immunosorbent assay.
Researchers found that increasing MIS serum concentrations were associated with increased breast cancer risk in this population.
“Additional research is needed, including confirmatory epidemiological studies on the association of serum MIS with breast cancer and studies aimed at identifying the biological mechanism underlying the association,” wrote the authors. (ANI)
- Drop in breast cancer rates linked to reduced hormone therapy - Dec 01, 2010
- Dense boobs linked to breast cancer return - Oct 08, 2010
- Study shows breast cancer risk factors differ among races - Apr 26, 2010
- Clinicians should carefully use X-rays on pregnant women, infants: Study - Feb 11, 2011
- Rust and sand could help detect cervical cancer, diarrhoea - Feb 01, 2011
- Study: Breast cancer linked to breast density - Oct 08, 2010
- Smoking doesn't boost breast cancer risk in obese postmenopausal women - Apr 04, 2011
- Household cleaners may double breast cancer risk - Jul 20, 2010
- Women born to older mothers may develop breast cancer - Feb 07, 2012
- Green tea no protection against breast cancer - Oct 29, 2010
- Green tea does not protect against breast cancer: Study - Oct 28, 2010
- Body fat distribution linked to a higher risk of ER-negative breast cancer - Dec 16, 2010
- Genetic variation that cuts bladder cancer risk identified - Apr 03, 2011
- Smoking ups death risk due to breast cancer - Nov 09, 2010
- Diabetes drug may provide protection against endometrial cancer - Apr 06, 2011
Tags: additional research, biological mechanism, blood samples, breast cancer, breast cancer patients, breast cancer risk, case control study, chase cancer center, columbia missouri, control subjects, dorgan, enzyme linked immunosorbent assay, epidemiological studies, fox chase cancer, fox chase cancer center, fox chase cancer center in philadelphia, invasive breast cancer, joanne, serum concentrations, sexual differentiation
